Markets
GNC

The seed is strong: Arcadia Biosciences files for a $86 million IPO

A generic image of a pen and a calculator
Credit: Shutterstock photo

Arcadia Biosciences, which is developing a portfolio of crop productivity traits for genetically modified seeds, filed on Tuesday with the SEC to raise up to $86 million in an initial public offering.

One of Arcadia's major customers is GNC ( GNC ), which purchases the company's only product, a branded safflower oil.

The company is backed by Moral Compass Corporation, the investment firm founded by John Sperling. Sperling founded Apollo Group ( APOL ), the parent company of the University of Phoenix.

The Davis, CA-based company, which was founded in 2002 and booked $6 million in sales for the 12 months ended September 30, 2014, plans to list on the NASDAQ under the symbol RKDA. Arcadia Biosciences initially filed confidentially on November 12, 2014. Credit Suisse, J.P. Morgan and Piper Jaffray are the joint bookrunners on the deal. No pricing terms were disclosed.

The article The seed is strong: Arcadia Biosciences files for a $86 million IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO) or the Global IPO Fund (symbol: IPOSX) , may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

GNC RKDA

Other Topics

IPOs